HCA Healthcare reports higher second-quarter revenue and lowers 2026 guidance

HCA Healthcare reported second-quarter 2026 revenue of $20.230 billion, up 8.7%, and net income attributable to the company of $1.699 billion, or $7.62 per diluted share, while operating cash flow fell to $2.335 billion from $4.210 billion a year earlier. HCA lowered its 2026 guidance to $77.0-$79.5 billion of revenue, $6.3-$6.7 billion of net income and $28.70-$30.50 of diluted EPS, citing an estimated $400 million second-quarter pretax impact from a shift toward uninsured patients; the company also declared a quarterly dividend of $0.78 per share payable September 30, 2026.